comparemela.com
Home
Live Updates
Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA ... : comparemela.com
Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA ...
SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company and its collaborators will present preliminary findings from the SPARTAN Study evaluating
Related Keywords
Japan ,
United Kingdom ,
Tokyo ,
Ryogoku ,
Chiba ,
Naomi Eichenbaum ,
Jula Inrig ,
Nivi Nehra ,
Nasdaq ,
Travere Therapeutics Inc ,
International Symposium On Iga Nephropathy ,
Corporate Communications ,
Exchange Commission ,
International Symposium ,
Iga Nephropathy ,
United Kingdom National Registry ,
Rare Renal Diseases ,
Incident Patients With Iga Nephropathy ,
First Line Therapy ,
Interim Findings From ,
Clinical Trial ,
Greater Extent Than ,
Disease Progression ,
Important Safety ,
Endothelin Receptor Antagonists ,
Upper Limit ,
Fetal Toxicity ,
Kidney Injury ,
Angiotensin System ,
Acid Reducing Agents ,
Steroidal Anti Inflammatory Agents ,
Including Selective ,
Increasing Serum Potassium ,
Reproductive Potential ,
Full Prescribing Information ,
Travere Therapeutics ,
Private Securities Litigation Reform Act ,
Region ,
comparemela.com © 2020. All Rights Reserved.